Football clubs in regional WA step up efforts to tackle suicide
Warning: This story discusses content some readers may find distressing.
The football community was shattered when former West Coast Eagles premiership player, Adam Selwood, died suddenly in May.
It was just months after his twin brother and former Brisbane player, Troy, died by suicide.
Now regional football clubs are taking a closer look at whether they are doing enough for players' mental health.
Data from suicide prevention advocacy group Think Mental Health shows one person from WA dies by suicide every day, with three out of four of those being men.
In Geraldton, about 400 kilometres north of Perth, sporting teams have felt the ripple effect of suicide too many times.
Railways Football Club head trainer Grant Russell said the impact left more questions than answers.
"Sadly I've lost a couple of close mates to suicide, I've also lost other people within the football club," Mr Russell said.
"When I lost a very good friend a few years ago to suicide I thought to myself, 'Why?'
Mr Russell, known to his club mates as Grunter, was diagnosed with bipolar almost 20 years ago.
He said hoped he could harness his experience to help others.
"I totally understand how you can feel lost in the darkness and think, 'Where do I go next?'" he said.
"I'm quite happy with the way I cope with my illness but it is something you must be conscious of every single day."
Earlier this month, the Railways community was rocked when a teammate tried to take their life.
It lit a fire under the club that change was needed.
"It shouldn't have taken that to kick us where it hurts to get ourselves aware and really talking about what the issues are," Mr Russell said.
The Great Northern Football League holds two mental health rounds within a season.
Mr Russell said he wanted to inspire meaningful conversations.
He was able to get the players and umpires to wear blue arm bands and added "Think Mental Health" covers to one of the point posts.
"There were a number of people that asked me, 'Grant, why is there one on one point post only' and I said, 'That's the point,'" he said.
"People are going to ask why and we can now open up and start talking about mental health.
In Northampton, 50 kilometres north of Geraldton, the local footy club has also struggled with mental health issues.
"We've lost some very close friends, cousins, relatives [to suicide]," Northampton Rams Football Club president Anthony Jupp said.
"I definitely think coming from the country it's more about the isolation and thinking no-one's there to help them.
"Definitely one [of our players] thought he was all alone but he didn't realise what he meant to the community, to all his friends and family."
Mr Jupp said the strong country mentality was a constant barrier to players seeking help.
He said a lot of players did not think they needed mental health support or would be too nervous to reach out on their own.
"But if we can get someone to come to the club and speak to the group as a whole I think, you know, if we only reach one or two, that's perfect," he said.
Mr Russell said he wanted people to know it was OK to not be OK.
"I know that [can be a] throwaway line that all campaigns use, but it is OK," he said.
After the passing of the Selwood brothers, Great Northern Football League president Carrissa Bellottie said she was shocked that mental-health rounds were not run at the national level.
"It definitely did come as a shock [because] we've had mental-health rounds here for years," she said.
"More recently Country Footy WA have got a new program called Tackle Your Feelings.
"So that no matter who you are, there's some sort of mental health program that you can reach out to at any given time."
The new initiative provides psychologist-led training for sporting clubs to identify and respond to poor mental health among members.
The AFL created a mental health strategy in 2020 and partners with the Black Dog Institute for the annual "Spud's game".
The AFL Players Association offers mental health support for current and former players.
In a written statement, WA Sports Minister Rita Saffioti said football clubs served as important platforms to talk about mental health.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

ABC News
11 hours ago
- ABC News
Matildas vs Slovenia international friendly — blog, scores and stats from Perth
After an uninspiring win against Slovenia on Thursday night, the Matildas are looking to step up a gear in the second friendly in Perth. Follow our live blog.

News.com.au
11 hours ago
- News.com.au
NSW Blues State of Origin Game 3 team: Bolters added to squad, Daley ignores calls for change
Laurie Daley is set to make no changes to his team for the State of Origin decider, backing in his existing squad for Game 3 in Sydney on July 9. Queensland levelled the series with a 26-24 win in Game 2, with the lopsided penalty count the main talking point from the game as the Maroons bounced back. FOX LEAGUE, available on Kayo Sports, is the only place to watch every game of every round in the 2025 NRL Telstra Premiership, LIVE with no ad-breaks during play. New to Kayo? Get your first month for just $1. Limited-time offer. NSW's forward pack came under scrutiny in Perth, with Max King's position at starting prop under question following the injury to Mitch Barnett that left a hole in the team. Stefano Utoikamanu's spot in the team was also seen as under threat, but Daley will stick with his guns and ignore calls to bring Rabbitohs gun Keaon Koloamatangi or Tigers recruit Terrell May in to do a job at prop. In this weekend's NRL games, Utoikamanu had 33min 60metres 24pcm 1 offload 20 tackles, Koloamatangi had 60min 108m 34pcm 32 tackles, and May had 68min 121m 56pcm 50 tackles, 0 missed. Fox League commentator Andrew Voss said on SEN after Game 2: 'Stefano Utoikamanu is gone. I'm rubbing him out for Game 3. Max King is not a starting Origin front rower. So there's a starting front rower spot up for grabs for NSW. 'I don't think you can go with the same starting 13 again. You can't go with Max King if you're only giving him that many minutes.' Daley has reportedly added Sharks second rower Teig Wilton and Parramatta forward Jack Williams to the extended squad for the 10-day camp before the decider at Sydney's Accor Stadium. According to Code Sports, Wilton and Williams won't be included in the final 20-man squad but will come into camp as experience and to run opposition at NSW training. On top of those two additions, Dolphins halfback Isaiya Katoa has been brought into NSW's squad as insurance for Nathan Cleary, who is managing a thigh/groin injury. Katoa, 21, has been in blistering form for the Dolphins and has been given the nod over Broncos veteran Adam Reynolds as the back-up halfback. Cleary starred in Penrith's win over the Bulldogs on Thursday and is expected to be fit to play in the Origin decider. Elsewhere, winger Brian To'o was cleared by the NRL judiciary of a high shot in Penrith's win, and he was also given the green light after undergoing scans for a knee injury. Jarome Luai has been cleared after being hospitalised with an infection, while superstar prop Payne Haas has been declared fit after battling a back injury. Canterbury winger Jacob Kiraz is expected to be named at 18th man for NSW. Queensland will name their team for Game 3 on Monday. Predicted NSW Blues team for Game 3 1. Dylan Edwards 2. Brian To'o 3. Stephen Crichton 4. Latrell Mitchell 5. Zac Lomax 6. Jarome Luai 7. Nathan Cleary 8. Max King 9. Reece Robson 10. Payne Haas 11. Liam Martin 12. Angus Crichton 13. Isaah Yeo (c) 14. Connor Watson 15. Spencer Leniu 16. Hudson Young 17. Stefano Utoikamanu 18th man: Jacob Kiraz

News.com.au
14 hours ago
- News.com.au
Green light for psychedelic drugs trial to treat binge-eating
Australian researchers will soon deploy a psychedelic compound found in 'magic mushrooms' to treat binge-eating in a world-first clinical trial. Experimental healthcare company Tryptamine Therapeutics announced the radical trial in a statement to the Australian Securities Exchange this week, telling investors Swinburne University would conduct the open-label research on 12 patients suffering from binge-eating disorder. Open-label means there are no placebos involved and all patients and researchers know what is being administered. The patients will receives two doses of TRP-8803, a psilocin-based IV infusion. Psilocin, which is produced when psilocybin is broken down in the body, is a psychedelic compound that triggers changes in mood, perception and thinking patterns. Cognitive neuropsychologist Professor Susan Rossell, from Swinburne, designed the trial with Tryptamine and told NewsWire she hoped the psychedelics would open up the trial's participants to new ways of thinking. 'What we have found in other psychedelics work is that the psychedelic itself opens up people to think differently,' she said. 'And one of the things that we know with a lot of mental health conditions, is they start to have repetitive thinking and it becomes very rigid. 'So people with binge eating disorder, 'I need to consume lots of food to help with my emotional issues'. 'They are in that very stuck, rigid thought pattern and they can't find other ways to deal with their life stressors.' Binge-eating is the uncontrollable consumption of food and can lead to a range of serious health problems, including social isolation and weight gain. It is the second most common eating disorder in Australia. In the US, an estimated 1.25 per cent of adults experience the disorder each year and 1.6 per cent of teenagers aged 13 to 18 are affected. 'It's extraordinarily costly,' Professor Rossell said. The trial is expected to run for three to four months, with initial results due at the end of the year. Tryptamine CEO Jason Carroll said the primary objective of the trial was to assess TRP-8803's utility in treating the disorder, but it could also generate insights into how the product might help with other neuropsychiatric disorders. 'With patient recruitment initiatives now underway, we look forward to first enrolment and the commencement of baseline data generation from participations, prior to first patient dosing,' he said. Clinical trials involving psychedelics to treat medical conditions are growing around the world, but the impacts are not yet clear. Psychedelic drugs are illegal in Australia and there is evidence that consuming mind-altering substances can lead to adverse outcomes. A study on single-dose Psilocybin for treatment-resistant depression, funded by psychedelics company Compass Pathways and published in the New England Journal of Medicine in 2022, revealed mixed results, with most participants experiencing 'adverse events'. 'Adverse events occurred in 179 of 233 participants (77 per cent) and included headache, nausea, and dizziness,' the researchers found. A small number of participants suffered serious negative impacts, the study revealed, including suicidal ideation and intentional self-injury. Professor Rossell said the Swinburne trial would be safe. 'I don't know whether these medications are going to work or not but I've worked with them now for two years and I haven't had anything negative happen with anybody in my trials, in the right and safe environment,' she said. She also said the use of an IV solution added an additional layer of control. 'The IV is even more safe,' she said. 'If we start to be aware that the person is having an unpleasant reaction, we can stop it straight away with the IV. 'With the oral preparations, they have to work through it. And it can leave people with some unpleasant feelings.' Tryptamine, a listed company with a market capitalisation of $43m, stresses the 'confirmed reversibility' of TRP-8803 as a key selling point for the product. 'This formulation aims to overcome several limitations of oral psilocybin, including significantly reducing the time to onset of the psychedelic state, controlling the depth and duration of the experience and reducing the overall duration of the intervention to a commercially feasible time-frame,' the company states. 'TRP-8803 also provides dosing flexibility and the ability to terminate treatment if the patient is experiencing an adverse event.' The company held $4.6m in cash as of March 31.